These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11281480)
21. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report]. Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542 [TBL] [Abstract][Full Text] [Related]
22. A case of supraventricular tachycardia associated with Wolff-Parkinson-White syndrome and pregnancy. Tak T; Berkseth L; Malzer R WMJ; 2012 Oct; 111(5):228-32. PubMed ID: 23189456 [TBL] [Abstract][Full Text] [Related]
24. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration. Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711 [TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of flecainide in the treatment of symptomatic children with Wolff-Parkinson-White syndrome. Núñez F; Ruiz-Granell R; Martínez-Costa C; Morell S; Brines J Pediatr Cardiol; 2010 Nov; 31(8):1162-5. PubMed ID: 20717658 [TBL] [Abstract][Full Text] [Related]
30. Use of maternal flecainide concentration in management of fetal supraventricular tachycardia: a step in the right direction. Cuneo BF; Benson DW Heart Rhythm; 2014 Nov; 11(11):2054-5. PubMed ID: 25128734 [No Abstract] [Full Text] [Related]
31. [Use of flecainide in the preventive treatment of tachycardia crisis of Wolff-Parkinson-White syndrome in 4 newborn infants]. Lupoglazoff JM; Jacqz-Aigrain E; Denjoy I; Casasoprana A Arch Fr Pediatr; 1991 Nov; 48(9):627-9. PubMed ID: 1763931 [TBL] [Abstract][Full Text] [Related]
32. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias. Orning OM Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821 [No Abstract] [Full Text] [Related]
33. Elimination of the delta wave in the Wolff-Parkinson-White syndrome. A misleading indicator of therapeutic effectiveness. Jordan J; Yamaguchi I; Mandel WJ Chest; 1978 Feb; 73(2):215-8. PubMed ID: 620586 [TBL] [Abstract][Full Text] [Related]
35. Transplacental flecainide therapy in the treatment of fetal supraventricular tachycardia. D'Souza D; MacKenzie WE; Martin WL J Obstet Gynaecol; 2002 May; 22(3):320-2. PubMed ID: 12521516 [No Abstract] [Full Text] [Related]
36. Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction. Ozaydín M; Varol E; Dogan A; Aslan SM; Altínbas A Minerva Cardioangiol; 2007 Jun; 55(3):427. PubMed ID: 17534262 [No Abstract] [Full Text] [Related]